论文部分内容阅读
目的分析蒙脱石散联合枫蓼肠胃康胶囊治疗急性肠炎的临床效果;方法本研究所选对象为我院2015年2月至2016年4月收治的急性肠炎患者80例,按照数字随机方式将全部患者分成两组,采用蒙脱石散治疗40例对照组患者,采用蒙脱石散联合枫蓼肠胃康胶囊治疗40例实验组患者;结果在临床治疗总有效率以及疾病复发率方面,实验组显著优于对照组患者(P<0.05);治疗期间两组患者均没有发生药物引起的不良反应。结论在对急性肠炎患者进行治疗时,蒙脱石散联合枫蓼肠胃康胶囊治疗具有比较显著的临床效果,值得临床应用。
Objective To analyze the clinical effect of montmorillonite powder combined with Fengliao Changweikang capsule in the treatment of acute enteritis.Methods Eighty patients with acute enteritis were treated in our hospital from February 2015 to April 2016. According to the random number All patients were divided into two groups, treated with montmorillonite powder in 40 patients in the control group, treated with montmorillonite powder combined with Fengliao Changweikang capsule in 40 patients in the experimental group. Results In the clinical treatment of total effective rate and disease recurrence rate, the experiment Group was significantly better than the control group patients (P <0.05); during the treatment of two groups of patients were no drug-induced adverse reactions. Conclusion In the treatment of patients with acute enteritis, montmorillonite combined with Fengliao Kangweichang capsule has a significant clinical effect, which is worth clinical application.